AstraZeneca Pharma India Limited

NSE:ASTRAZEN.NS

7972 (INR) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 4,402.94,0803,875.23,831.9883,057.893,110.72,954.6682,847.0272,498.0852,361.2682,323.322,319.6322,005.2721,977.0761,754.022,052.5332,002.522,094.7711,935.7761,948.6282,238.6282,084.8312,045.6131,902.4842,151.941,613.6081,614.3681,507.2231,285.3861,642.5831,274.8081,157.0881,502.8611,381.6541,395.4081,335.1481,445.6081,283.531,200.3121,208.0371,081.2231,145.5021,255.7261,141.4941,188.7921,155.8241,251.372934.221,049.139992.282912.608915.4631,535.221
Cost of Revenue 2,470.32,259.32,953.12,752.9211,482.9151,221.2951,693.5861,639.153914.67865.078833.7991,330.772776.57802.577664.6811,121.222683.048775.552725.5781,455.162813.176741.548700.3911,271.889649.211527.265533.482926.783792.9534.535451.454658.859470.504442.238447.488654.357540.681468.707464.331574.753387.41530.364536.988678.178387.56392.59433.372502.583403.924437.213379.163519.105472.774
Gross Profit 1,932.61,820.7922.11,079.0671,574.9751,889.4051,261.0821,207.8741,583.4151,496.191,489.521988.861,228.7021,174.4991,089.339931.3111,319.4721,319.2191,210.198493.4661,425.4521,343.2831,345.222630.5951,502.7291,086.3431,080.886580.44492.4861,108.048823.354498.2291,032.357939.416947.92680.791904.927814.823735.981633.283693.813615.138718.738463.315801.232763.234818431.636645.215555.069533.445396.3581,062.447
Gross Profit Ratio 0.4390.4460.2380.2820.5150.6070.4270.4240.6340.6340.6410.4260.6130.5940.6210.4540.6590.630.6250.2530.6370.6440.6580.3310.6980.6730.670.3850.3830.6750.6460.4310.6870.680.6790.510.6260.6350.6130.5240.6420.5370.5720.4060.6740.660.6540.4620.6150.5590.5850.4330.692
Reseach & Development Expenses 0000000000000000000000000000000000000000000102.813000163.71200000
General & Administrative Expenses 00396.8411.3820.0290.037413.945299.30.200280000318.900.20273.5000262.800271.161212.918371.16500193.135381.19377.696423.254200.494388.128254.43500241.42100201.249000208.24500000
Selling & Marketing Expenses 227.4217.4183.7211.445283.5152.4212.661202.655207.671144.324107.35224.102144.57398.38102.845161.446143.289114.67992.386130.686116.965140.117169.833272.718165.137116.843286.202250.379245.681152.649118.591129.931186.129143.866126.493302.21138.72157.059200.1930150.26200555.402000507.18200000
SG&A 227.4217.4580.5622.827283.529152.437626.606501.955207.871144.324107.35504.102144.57398.38102.845480.346143.289114.87992.386404.186116.965140.117169.833535.518165.137116.843286.202395.479616.846152.649118.591323.066567.319143.866549.747502.704526.848411.494200.193671.594391.683403.201437.541756.651350.317367.490715.427-177.20200-540.777219.61
Other Expenses 1,0261,171.3001,17800705.9191,052.376977.591,148.461144.9791,084.1291,076.119986.49496.1411,176.1831,204.541,117.81201,308.4871,203.1661,175.389380.626966.603978.5160246.6660636.388704.763260.181355.817426.826279.149185.173306.345485.091525.754-38.31447.248507.605475.129553.464451.524436.316818431.636822.417555.069533.445938.569842.449
Operating Expenses 1,253.41,388.7580.5622.8271,461.4541,889.51,214.3331,207.8741,260.0471,121.9141,255.811649.0811,228.7021,174.4991,089.339576.4871,319.4721,319.2191,210.198752.9121,425.4521,343.2831,345.222891.5151,131.741,095.3591,090.321642.145900.953789.037823.354583.247923.136939.416828.896687.878904.927896.585735.981633.283838.931615.138912.67553.464801.232803.806818431.636645.215555.069533.445397.7931,062.059
Operating Income 679.2432341.6475.45113.51,069.176634.6556.246324.568374.276233.73339.779111.613136.407108.701354.824256.331311.542240.103107.134319.924289.19309.35324.629370.989110.89357.311142.958-145.758319.01125.08956.778109.22-8.394119.024-7.08771.947-66.8910.034403.728-134.09-279.6-193.932-251.599-0.609-40.572-11.052-180.229-179.116-208.161-131.834-542.212219.998
Operating Income Ratio 0.1540.1060.0880.1240.0370.3440.2150.1950.130.1590.1010.1460.0560.0690.0620.1730.1280.1490.1240.0550.1430.1390.1510.0130.1720.0690.0360.095-0.1130.1940.020.0490.073-0.0060.085-0.0050.05-0.0520.0080.334-0.124-0.244-0.154-0.22-0.001-0.035-0.009-0.193-0.171-0.21-0.144-0.5920.143
Total Other Income Expenses Net -25978.3-493.268.13590.493-335.33279.378-323.49469.99666.41839.2630.56451.03325.96426.33913.52426.67844.15723.74126.48831.90228.77226.93860.1734.95733.54534.208-2.39427.59724.95746.541-76.6998.32718.16415.6217.70614.795017.131-22.4330017.93225.91115.78833.39728.736-5.5232.1630052.6440
Income Before Tax 420.2510.3-151.6543.585203.993733.844713.978232.752394.564440.694272.99370.343162.646162.371135.04368.348283.009355.699263.844133.622351.826317.962336.29184.799405.946144.43891.519140.564-118.161343.96871.63-19.913207.5479.77134.64410.61986.742-66.8927.165381.295-134.09-279.6-176.002-25.68815.179-7.17517.684-185.752-176.953-208.161-131.834-489.568219.998
Income Before Tax Ratio 0.0950.125-0.0390.1420.0670.2360.2420.0820.1580.1870.1170.160.0810.0820.0770.1790.1410.170.1360.0690.1570.1530.1640.0450.1890.090.0570.093-0.0920.2090.056-0.0170.1380.0070.0960.0080.06-0.0520.0230.316-0.124-0.244-0.14-0.0230.013-0.0060.014-0.199-0.169-0.21-0.144-0.5350.143
Income Tax Expense 111.7126-33.7148.79945.984210.146175.37160.065101.52115.05171.46490.43848.45442.90132.60795.59472.49392.31577.49737.84584.809173.809121.137-13.536115.02853.12227.585108.401-14.63970.1213.6578.84147.9181.90428.9635.0470000000005.089000242.997-50.374-159.52370.624
Net Income 308.5384.3-117.9394.786158.009523.698538.6172.687293.044325.643201.526279.905114.192119.47102.433272.754210.516263.384186.34795.777267.017144.153215.15498.335290.91891.31663.93432.163-103.522273.84857.973-28.753159.6297.866105.6815.57386.742-66.8927.165381.295-134.09-279.6-176.002-25.68815.178-12.26417.684-185.752-176.953-451.158-81.46-330.045149.374
Net Income Ratio 0.070.094-0.030.1030.0520.1680.1820.0610.1170.1380.0870.1210.0570.060.0580.1330.1050.1260.0960.0490.1190.0690.1050.0520.1350.0570.040.021-0.0810.1670.045-0.0250.1060.0060.0760.0040.06-0.0520.0230.316-0.124-0.244-0.14-0.0230.013-0.0110.014-0.199-0.169-0.455-0.089-0.3610.097
EPS 12.3415.37-4.7215.796.3220.9521.546.9111.7213.038.0611.214.574.784.110.918.4210.647.453.8310.685.778.613.9411.643.652.581.29-4.1410.952.32-3.826.480.325.040.223.47-2.681.0915.26-5.36-11.18-7.04-1.040.61-0.490.71-7.43-7.08-18.05-3.26-13.215.97
EPS Diluted 12.3415.37-4.7215.796.3220.9521.546.9111.7213.038.0611.24.574.784.110.918.4210.647.453.8310.685.778.613.9411.643.652.581.29-4.1410.952.32-3.826.480.325.040.223.47-2.681.0915.26-5.36-11.18-7.04-1.030.61-0.490.71-7.43-7.08-18.05-3.26-13.215.97
EBITDA 514.2606.9-111.4581.176247.166775.584753.492276.089437.852475.189320.79416.445199.974207.597185.307425.696336.717404.687312.199181.835402.251367.204382.565-38.953443.756181.176127.023176.076-80.86381.453108.7116.837247.73950.399175.333-11.514131.188-22.27870398.892-90.343-245.014-141.711-225.48330.08616.27435.443-223.301-151.552-183.13-114.32-524.108238.879
EBITDA Ratio 0.1170.149-0.0290.1520.0810.2490.2550.0970.1750.2010.1380.180.10.1050.1060.2070.1680.1930.1610.0930.180.1760.187-0.020.2060.1120.0790.117-0.0630.2320.0850.0150.1650.0360.126-0.0090.091-0.0170.0580.33-0.084-0.214-0.113-0.1980.0250.0140.028-0.239-0.144-0.185-0.125-0.5730.156